Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Hjertetaktsvariabilitet Biofeedback i Sikkerhetsstyrker (GNR-HRVB)

Hjertefrekvensvariabilitet Biofeedback i Distressregulering og Forebygging av Utbrenthet Blant Sikkerhetsstyrker

This exploratory study evaluates the effectiveness of a 12-session Heart Rate Variability Biofeedback (HRV-BFB) protocol in reducing distress and burnout while promoting psychological well-being among Portuguese National Republican Guard (GNR) professionals. Exposed to high occupational stress from unpredictable risks, shift work, and limited resources, these individuals face elevated vulnerability to chronic stress outcomes. The intervention leverages real-time HRV feedback to enhance autonomic regulation, breathing techniques, and emotional self-regulation.

Studieoversikt

Detaljert beskrivelse

Security forces like the GNR play a critical role in public safety but endure chronic stress from violence exposure, rapid decisions, shift rotations, and institutional resource shortages, heightening risks of distress, burnout, and impaired well-being. Distress arises when perceived threats exceed coping resources, leading to persistent negative emotions and health disruptions. Burnout manifests as exhaustion, mental distancing, and reduced efficacy from unmanaged chronic stress, with organizational impacts including absenteeism and eroded public trust. Psychological well-being encompasses multidimensional aspects like autonomy, relationships, and purpose beyond mere absence of illness. Traditional interventions face barriers such as stigma and access issues in rural GNR contexts, necessitating flexible, self-administered tools.

Intervention: HRV-BFB Protocol HRV-BFB trains participants to consciously modulate physiological responses via real-time monitoring of heart rate variability (HRV), reflecting sympathetic-parasympathetic balance. Low HRV links to mental health risks, while training targets resonance frequency breathing (~6 breaths/min or 0.1 Hz) to boost HRV amplitude, cardiac coherence, and baroreflex strength. Delivered autonomously via app post-initial guidance, the 12-session protocol requires no daily clinician oversight, enhancing accessibility for dispersed GNR personnel. Evidence shows HRV-BFB reduces stress, anxiety, depression, and burnout while fostering well-being in high-stress groups like emergency workers.

Study Objectives This exploratory trial tests whether HRV-BFB significantly lowers distress (multidimensional: physical, cognitive, emotional, behavioral), burnout levels, and boosts psychological well-being in GNR professionals. It aims to inform scalable interventions tailored to Portuguese police realities, addressing gaps in institutional support.

Studietype

Intervensjonell

Registrering (Faktiske)

38

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Setúbal, Portugal
        • GNR - Comando Terrritorial de Setúbal (GNR - Setubal Territorial Command Centre)

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 55 år (Voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Operational military personnel of the Guarda Nacional Republicana (GNR) performing security, patrol, criminal investigation, or road safety duties
  2. Any military rank or professional category within operational roles
  3. Age between 18 and 55 years, inclusive
  4. Both males and females
  5. Capable of providing informed consent in Portuguese language

Exclusion Criteria:

  1. Extended sick leave or medical absence
  2. Currently involved in serious disciplinary proceedings
  3. Use, modification, or initiation of psychotropic medication (including antidepressants, anti-anxiety medications, antipsychotics, mood stabilizers) within the past 6 months

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: HRV Biofeedback Training

Participants receive 12 individual sessions of heart rate variability biofeedback (HRV-BFB) over 4 weeks (one 12-minute session every 2 days). Training is delivered using a chest-worn ECG sensor (eSense Pulse) connected to a mobile application that provides real-time visual feedback.

Participants receive a structured heart rate variability biofeedback (HRV-BFB) training protocol delivered over 4 weeks. The intervention uses a portable chest-worn ECG sensor (eSense Pulse) connected via Bluetooth to a mobile application that provides real-time visual feedback of heart rate variability. Each participant completes 12 individual sessions of 12 minutes each (one session every 2 days). Sessions take place in a quiet room and follow a standardized format: a brief preparation phase, followed by approximately 10 minutes of guided breathing at resonance frequency (around 6 breaths per minute) using a visual breathing guide. The application displays color-coded feedback indicating how closely the participant's physiological response matches the target HRV pattern, and participants are instructed to adjust their breathing and recall positive memories to maximize time in the desired state. The aim is to increase HRV, strengthen parasympathetic activation, and improve stress and

Andre navn:
  • HRV biofeedback
  • Resonansfrekvens pustetrening
Ingen inngripen: Control: No Intervention

Participants receive no active intervention during the 4-week study intervention period and continue their usual duties and routines. They complete the same assessment schedule as the experimental group at baseline, 4 weeks, and 10 weeks. After completion of the final follow-up assessment, they are offered the opportunity to receive the HRV biofeedback training protocol.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Psychological Distress (Kessler Psychological Distress Scale - K10)
Tidsramme: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

The Kessler Psychological Distress Scale (K-10) is a 10-item self-report measure assessing psychological distress over the past 30 days. Items measure anxiety and depressive symptoms on a 5-point Likert scale (1=never to 5=always). Total score range: 10-50 (higher scores indicate greater distress). Portuguese validation: α=0.91. Primary outcome is change from baseline to post-intervention (week 4) and follow-up (week 10).

Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)
Change in Occupational Burnout (Burnout Assessment Tool - BAT-12)
Tidsramme: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

The Burnout Assessment Tool Short Form (BAT-12) is a 12-item self-report measure of occupational burnout across 4 dimensions: exhaustion (3 items), mental distance (3 items), cognitive impairment (3 items), emotional impairment (3 items). 5-point Likert scale (1=never to 5=always). Total score range: 12-60. Portuguese validation: α=0.85. Primary outcome is change from baseline to post-intervention and follow-up.

Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)
Change in Psychological Well-Being (WHO-5 Well-Being Index)
Tidsramme: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

The WHO-5 Well-Being Index is a 5-item self-report measure of psychological well-being over the past 2 weeks. Items assess positive mood, vitality, sleep, daily functioning, and life satisfaction on a 0-5 scale. Total score range: 0-25 (higher=higher well-being). Primary outcome is change from baseline to post-intervention and follow-up.

Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
SDNN (Standard Deviation of NN Intervals) - Heart Rate Variability
Tidsramme: Baseline (Week 0), after each of 12 training sessions

SDNN measures the standard deviation of the average NN (R-R) intervals in milliseconds during a recording period. It is a general indicator of overall heart rate variability and reflects the body's overall capacity for physiological adaptation and autonomic flexibility. Higher SDNN values indicate better autonomic regulation.

Baseline (Week 0), after each of 12 training sessions
RMSSD (Root Mean Square of Successive Differences) - Parasympathetic Activity
Tidsramme: Baseline (Week 0), after each of 12 training sessions

RMSSD measures the root mean square of successive differences between adjacent NN (R-R) intervals in milliseconds. It is a primary time-domain measure of high-frequency heart rate variability and specifically reflects parasympathetic (vagal) nervous system activity and the body's recovery capacity. Higher RMSSD indicates stronger parasympathetic tone.

Baseline (Week 0), after each of 12 training sessions
Stress Index - Autonomic Balance Indicator
Tidsramme: Baseline (Week 0), after each of 12 training sessions

The Stress Index is a proprietary metric derived from heart rate variability analysis that quantifies autonomic nervous system balance. Lower values indicate better autonomic regulation and lower physiological stress levels. Higher values reflect sympathetic dominance and poorer stress adaptation.

Baseline (Week 0), after each of 12 training sessions

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

28. januar 2026

Primær fullføring (Faktiske)

20. september 2026

Studiet fullført (Faktiske)

20. september 2026

Datoer for studieregistrering

Først innsendt

28. januar 2026

Først innsendt som oppfylte QC-kriteriene

28. januar 2026

Først lagt ut (Faktiske)

4. februar 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

3. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

2. november 2026

Sist bekreftet

1. januar 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere